Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Size limits of magnetic-domain engineering in continuous in-plane exchange-bias prototype films.
Gaul A, Emmrich D, Ueltzhöffer T, Huckfeldt H, Doğanay H, Hackl J, Khan MI, Gottlob DM, Hartmann G, Beyer A, Holzinger D, Nemšák S, Schneider CM, Gölzhäuser A, Reiss G, Ehresmann A. Gaul A, et al. Among authors: hackl j. Beilstein J Nanotechnol. 2018 Dec 3;9:2968-2979. doi: 10.3762/bjnano.9.276. eCollection 2018. Beilstein J Nanotechnol. 2018. PMID: 30591845 Free PMC article.
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
Gnant M, Fitzal F, Rinnerthaler G, Steger GG, Greil-Ressler S, Balic M, Heck D, Jakesz R, Thaler J, Egle D, Manfreda D, Bjelic-Radisic V, Wieder U, Singer CF, Melbinger-Zeinitzer E, Haslbauer F, Sevelda P, Trapl H, Wette V, Wimmer K, Gampenrieder SP, Bartsch R, Kacerovsky-Strobl S, Suppan C, Brunner C, Deutschmann C, Soelkner L, Fesl C, Greil R; Austrian Breast and Colorectal Cancer Study Group. Gnant M, et al. N Engl J Med. 2021 Jul 29;385(5):395-405. doi: 10.1056/NEJMoa2104162. N Engl J Med. 2021. PMID: 34320285 Clinical Trial.
Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial.
Keil F, Hartl M, Altorjai G, Berghold A, Riedl R, Pecherstorfer M, Mayrbäurl B, De Vries A, Schuster J, Hackl J, Füreder T, Melchardt T, Burian M, Greil R. Keil F, et al. Among authors: hackl j. Eur J Cancer. 2021 Jul;151:201-210. doi: 10.1016/j.ejca.2021.03.051. Epub 2021 May 19. Eur J Cancer. 2021. PMID: 34022697 Clinical Trial.
Clarifications concerning the commentary "Published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed".
Koch MC, Lermann J, van de Roemer N, Renner SK, Burghaus S, Hackl J, Dittrich R, Kehl S, Oppelt PG, Hildebrandt T, Hack CC, Pöhls UG, Renner SP, Thiel FC. Koch MC, et al. Among authors: hackl j. Reprod Health. 2019 Jun 17;16(1):83. doi: 10.1186/s12978-019-0746-1. Reprod Health. 2019. PMID: 31208442 Free PMC article. No abstract available.
Standards Used by a Clinical and Scientific Endometriosis Center for the Diagnosis and Therapy of Patients with Endometriosis.
Burghaus S, Hildebrandt T, Fahlbusch C, Heusinger K, Antoniadis S, Lermann J, Hackl J, Häberle L, Renner SP, Fasching PA, Beckmann MW, Blum S. Burghaus S, et al. Among authors: hackl j. Geburtshilfe Frauenheilkd. 2019 May;79(5):487-497. doi: 10.1055/a-0813-4411. Epub 2019 Feb 28. Geburtshilfe Frauenheilkd. 2019. PMID: 31148849 Free PMC article.
Retraction Note: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app.
Koch MC, Lermann J, van de Roemer N, Renner SK, Burghaus S, Hackl J, Dittrich R, Kehl S, Oppelt PG, Hildebrandt T, Hack CC, Pöhls UG, Renner SP, Thiel FC. Koch MC, et al. Among authors: hackl j. Reprod Health. 2019 May 14;16(1):54. doi: 10.1186/s12978-019-0728-3. Reprod Health. 2019. PMID: 31088503 Free PMC article.
100 results